NCT05449717View on ClinicalTrials.gov

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

April 11, 2025

Study Completion Date

April 11, 2025

Conditions
LeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis
Trial Locations (1)

Unknown

Lankien Hospital, Lankien

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

collaborator

Drugs for Neglected Diseases

OTHER

collaborator

Medecins Sans Frontieres, Netherlands

OTHER

lead

Epicentre

OTHER